Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 412.5 GBX -1.43% Market Closed
Market Cap: 434.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Oxford BioMedica PLC
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Oxford BioMedica PLC
Accounts Payable Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Oxford BioMedica PLC
LSE:OXB
Accounts Payable
ÂŁ13m
CAGR 3-Years
8%
CAGR 5-Years
20%
CAGR 10-Years
32%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Accounts Payable
$11.8m
CAGR 3-Years
128%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Accounts Payable
$103k
CAGR 3-Years
-64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Accounts Payable
$5.7m
CAGR 3-Years
47%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Accounts Payable
ÂŁ17.8m
CAGR 3-Years
45%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Accounts Payable
ÂŁ123.2m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
9%

See Also

What is Oxford BioMedica PLC's Accounts Payable?
Accounts Payable
13m GBP

Based on the financial report for Jun 30, 2024, Oxford BioMedica PLC's Accounts Payable amounts to 13m GBP.

What is Oxford BioMedica PLC's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
32%

Over the last year, the Accounts Payable growth was 41%. The average annual Accounts Payable growth rates for Oxford BioMedica PLC have been 8% over the past three years , 20% over the past five years , and 32% over the past ten years .

Back to Top